
1. malar j. 2017 may 30;16(1):228. doi: 10.1186/s12936-017-1877-x.

molecular immunological analyses confirmed plasmodium vivax relapse
episodes.

maneerattanasak s(1), gosi p(2), krudsood s(3), chimma p(4), tongshoob j(1),
mahakunkijcharoen y(1), sukasem c(5)(6), imwong m(7), snounou g(8), khusmith
s(9)(10).

author information: 
(1)department microbiology immunology, faculty tropical medicine,
mahidol university, 420/6 rajvithi road, bangkok, 10400, thailand.
(2)department immunology medicine, armed forces research institute of
medical science-united states army military component, bangkok, thailand.
(3)clinical malaria research unit, faculty tropical medicine, mahidol
university, bangkok, thailand.
(4)office research development, faculty medicine siriraj hospital,
mahidol university, bangkok, 10700, thailand.
(5)division pharmacogenomics personalized medicine, department of
pathology, faculty medicine ramathibodi hospital, mahidol university, bangkok,
10400, thailand.
(6)laboratory pharmacogenomics, somdech phra debaratana medical center
(sdmc), ramathibodi hospital, bangkok, thailand.
(7)department molecular tropical medicine genetics, faculty tropical
medicine, mahidol university, bangkok, 10400, thailand.
(8)upmc univ paris 06, inserm (institut national de la santé et de la recherche
medicale), centre d'immunologie et des maladies infectieuses (cimi-paris), umr
1135, erl cnrs 8255 (centre national de la recherche scientifique), sorbonne
universités, 91 boulevard de l'hôpital, 75013, paris, france.
(9)department microbiology immunology, faculty tropical medicine,
mahidol university, 420/6 rajvithi road, bangkok, 10400, thailand.
srisin.khu@mahidol.ac.th.
(10)center emerging neglected infectious diseases, mahidol university,
bangkok, thailand. srisin.khu@mahidol.ac.th.

background: relapse infections resulting activation hypnozoites produced
by plasmodium vivax plasmodium ovale represent important obstacle the
successful control species. single licensed drug, primaquine is
available eliminate liver dormant forms. date, investigations of
vivax relapse infections number.
results: genotyping, based polymorphic regions two genes (pvmsp1f3 and
pvcsp) four microsatellite markers (ms3.27, ms3.502, ms6 ms8), 12
paired admission relapse samples p. vivax-infected patients treated
with primaquine, revealed eight parasite populations the
admission relapse samples homologous, heterologous remaining 
four patients. patients' cyp2d6 genotypes suggest poor 
metabolisers primaquine. parasitaemia tended higher heterologous 
as compared homologous relapse episodes igg3 response. 
twelve pro- anti-inflammatory cytokine levels measured samples, 
those il-6 il-10 tended higher patients heterologous as
compared homologous relapses admission relapse episodes.
conclusions: data limited number patients confirmed relapse
episodes mirror previous observations significant proportion heterologous
parasites relapses p. vivax infections thailand. failure the
primaquine treatment patients received unlikely due poor
drug metabolism, could indicate presence p. vivax populations in
thailand poor susceptibility 8-aminoquinolines.

doi: 10.1186/s12936-017-1877-x 
pmcid: pmc5450361
pmid: 28558712  [indexed medline]

